• Aji Bio-Pharma, DNDi Enter Strategic Supply Pact contractpharma
    October 09, 2020
    Aji Bio-Pharma will manufacture CpG-D35, a class of CpG oligonucleotides to be used in the treatment of cutaneous leishmaniasis infections.
  • Aji Bio-Pharma Forms External Advisory Board contractpharma
    March 10, 2020
    Ajinomoto Bio-Pharma Services (Aji Bio-Pharma), a provider of biopharmaceutical contract development and manufacturing services, has formed an External Advisory Board (EAB) to provide insight into industry trends ...
PharmaSources Customer Service